Literature DB >> 24217288

A target-oriented algorithm for citrate-calcium anticoagulation in clinical practice.

Karin Strobl1, Jens Hartmann, Manfred Wallner, Martin Brandl, Dieter Falkenhagen.   

Abstract

BACKGROUND/AIMS: Because of a high monitoring demand and an ensuing need for automation of regional citrate anticoagulation (RCA), a new semi-automated target-oriented algorithm was developed. The aim of this study was the evaluation of its functionality and safety.
METHODS: Fourteen haemodialysis patients were treated 5 times consecutively with RCA. Samples were drawn pre- and post-infusion once per hour. Electrolytes, blood cell counts, acid-base and coagulation parameters were analyzed.
RESULTS: Mean ionized calcium (Ca(2+)) values pre-filter were 0.23 and 0.33 mmol/l in the 0.2 and 0.3 mmol/l target groups, respectively. Extraction ratios for citrate and total calcium through the dialysis filter were constant during the entire treatment (83 and 68%, respectively). Citrate accumulation was avoided.
CONCLUSION: The new algorithm enables safe and accurate RCA. By regulating Ca(2+) pre-filter using the target-oriented algorithm, the degree of anticoagulation may be easily controlled.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217288     DOI: 10.1159/000355012

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

Review 1.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

2.  Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.

Authors:  Jakob Gubensek; Alesa Orsag; Rafael Ponikvar; Jadranka Buturovic-Ponikvar
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

3.  Simple citrate anticoagulation protocol for low flux haemodialysis.

Authors:  Eng Kuang Lim; Ying-Ying T Seow; Shun E Chen; Gao Yang; Min Er Liaw; Shimi Isaac
Journal:  BMC Nephrol       Date:  2018-01-19       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.